Compare BWEN & INCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BWEN | INCR |
|---|---|---|
| Founded | N/A | 1994 |
| Country | United States | Israel |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 51.0M | 42.3M |
| IPO Year | 2009 | 2021 |
| Metric | BWEN | INCR |
|---|---|---|
| Price | $2.19 | $0.76 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $6.00 | N/A |
| AVG Volume (30 Days) | ★ 99.3K | 22.1K |
| Earning Date | 05-12-2026 | 03-30-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 360.00 | N/A |
| EPS | ★ 0.23 | N/A |
| Revenue | ★ $146,785,000.00 | N/A |
| Revenue This Year | N/A | $69.54 |
| Revenue Next Year | $17.37 | $41.75 |
| P/E Ratio | $9.09 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $1.49 | $0.68 |
| 52 Week High | $4.15 | $1.77 |
| Indicator | BWEN | INCR |
|---|---|---|
| Relative Strength Index (RSI) | 50.91 | 44.88 |
| Support Level | $1.90 | $0.72 |
| Resistance Level | $2.23 | $0.79 |
| Average True Range (ATR) | 0.12 | 0.03 |
| MACD | 0.03 | 0.01 |
| Stochastic Oscillator | 91.38 | 57.31 |
Broadwind Inc is a precision manufacturer of structures, equipment and components for clean technology and other specialized applications. The company provide technologically high value products to customers with complex systems and stringent quality standards that operate in energy, mining and infrastructure sectors, in the United States of America. It capabilities include heavy fabrications, welding, metal rolling, coatings, gear cutting and shaping, gearbox manufacturing and repair, heat treat, assembly, engineering and packaging solutions. It operates through four operating segments namely Heavy Fabrications, Gearing, Industrial Solutions and Corporate.
Intercure Ltd is engaged in the research, cultivation, production, and distribution of pharma-grade cannabis-based products. Its products are available in dried inflorescences or liquid oil form, and are marketed through various brands, including Pharmo Cann, Humboldt, Indoor, Space Labs, Canndoc Utopia, Binske, Canndoc Stars, and others. The company has two operating segments, namely Investments in portfolio companies in the biomed sector and Investments in the medical cannabis sector. A majority of its revenue is generated from the Cannabis segment.